BioMarin appoints Robert Plenge to board, expanding to 11 members

BIOMARIN PHARMACEUTICAL INC

Board increased from 10 to 11 members; Robert Plenge, M.D., Ph.D. appointed effective September 10, 2026.
Plenge also named to Science and Technology Committee as an independent non-employee director.
Granted RSUs valued at $400,000 under 2017 Equity Incentive Plan, vesting before next annual meeting.
Eligible for standard non-employee director fees and committee retainers per April 21, 2026 proxy statement.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Robert Plenge, M.D., Ph.D.

Director

BMRN · BIOMARIN PHARMACEUTICAL INC

Effective: 2026-09-10
Filed: September 14, 2026, 9:26 AM ET

appointed Robert Plenge, M.D., Ph.D., to the Board, to be effective September 10, 2026

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Plenge, M.D., Ph.D. was appointed as Director at BIOMARIN PHARMACEUTICAL INC.

Action: appointed
Role: Director

Exact text from the filing

appointed Robert Plenge, M.D., Ph.D., to the Board, to be effective September 10, 2026

View on SEC.gov

BIOMARIN PHARMACEUTICAL INC filing history →

Source: SEC EDGAR

accession 0001628280-26-061717

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.